BFTHX
Price
$66.23
Change
-$1.85 (-2.72%)
Updated
Nov 13 closing price
Net Assets
791.28M
VIGRX
Price
$248.63
Change
-$5.44 (-2.14%)
Updated
Nov 13 closing price
Net Assets
357.2B
Interact to see
Advertisement

BFTHX vs VIGRX

Header iconBFTHX vs VIGRX Comparison
Open Charts BFTHX vs VIGRXBanner chart's image
Baron Fifth Avenue Growth Retail
Price$66.23
Change-$1.85 (-2.72%)
VolumeN/A
Net Assets791.28M
Vanguard Growth Index Investor
Price$248.63
Change-$5.44 (-2.14%)
VolumeN/A
Net Assets357.2B
BFTHX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
BFTHX vs. VIGRX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFTHX is a Hold and VIGRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. BFTHX (791M). VIGRX pays higher dividends than BFTHX: VIGRX (0.30) vs BFTHX (0.00). BFTHX was incepted earlier than VIGRX: BFTHX (22 years) vs VIGRX (33 years). BFTHX (1.03) is less costly to investors than VIGRX (0.17). BFTHX is a more actively managed with annual turnover of: 26.00 vs. VIGRX (11.00). BFTHX has a lower initial minimum investment than VIGRX: BFTHX (2000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 20.72 vs. BFTHX (18.30). VIGRX return over 5 years is better than : 107.23 vs. BFTHX (44.60).
BFTHXVIGRXBFTHX / VIGRX
Total Expense Ratio1.000.17588%
Annual Report Gross Expense Ratio1.030.17606%
Fund Existence22 years33 years-
Gain YTD19.04220.24794%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets791M357B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year18.3020.7288%
Returns for 3 years128.30114.58112%
Returns for 5 years44.60107.2342%
Returns for 10 years273.86367.6574%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGRY15.860.11
+0.73%
Surgery Partners
ENVB5.980.04
+0.67%
Enveric Biosciences Inc.
ASND199.22-1.94
-0.96%
Ascendis Pharma A/S
HNNA9.92-0.17
-1.64%
Hennessy Advisors
FBYD12.14-1.18
-8.86%
Falcon's Beyond Global Inc